Current Oncology Reports

Article	Citations
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer	163
Treatment Following Progression in Metastatic Melanoma: the State of the Art from Scientific Literature to Clinical Need	124
Dealing with Family Conflicts in Decision-making in End-of-Life Care of Advanced Cancer Patients	100
Richter’s Transformation	98
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success	66
Diagnostic and Therapeutic Updates in Leptomeningeal Disease	65
Prostate Cancer Immunotherapy—Finally in From the Cold?	64
Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications	61
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives	60
Asparaginase: How to Better Manage Toxicities in Adults	56
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach	55
The Role of Patient Support Groups in Neuroendocrine Neoplasms	52
Immune Checkpoint Inhibitors in the Aged	48
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	47
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade	41
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge	39
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	39
Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?	39
Approach to the Older Patient with Acute Myeloid Leukemia	37
Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer	37
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?	33
Progress Update in Pediatric Renal Tumors	33
What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?	33
Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment	30
Immunotherapy in Biliary Tract Cancers: Where Are We?	30

Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma	30
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment	29
Current Management of Refractory Germ Cell Tumors	29
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach	29
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours	28
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis	28
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis	27
Germline Mutations and Ancestry in Prostate Cancer	27
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development	26
Current Understanding and Management of Intraductal Carcinoma of the Prostate	26
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	26
Incorporation of Palliative Care in Gynecologic Oncology	25
The Emerging Role of Next-Generation Imaging in Prostate Cancer	25
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies	24
First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly	23
Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse	22
New Treatments for Recurrent Uterine Cancer	22
Hairy Cell Leukemia: Where Are We in 2023?	22
Metronomic Chemotherapy in Elderly Patients	21
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	21
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy	21
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections	21
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	20
Emerging Role of PARP Inhibitors in Metastatic Prostate Cancer	20
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?	20
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	19
The Care of the Leukemic Patients in Times of SARS-CoV-2	19
Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease	19
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer	19
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice	19
Management of Upper Tract Urothelial Carcinoma	18
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	18
Fatty Acid Metabolism and Cancer Immunotherapy	18
Graft-Versus-Host Disease: an Update on Functional Implications and Rehabilitation Interventions	18
Cardiovascular Toxicities of CAR T-cell Therapy	17
The Concept of Respite in Palliative Care: Definitions and Discussions	17
Surgical Management of Melanoma: Advances and Updates	17
Quality of Life and Survivorship in Lymphoma	17
WEE1 Inhibitor: Clinical Development	17
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions	17
CAR T-Cell Therapy in the Older Person: Indications and Risks	17
Kidney Cancer Integrative Oncology: Possible Options for Care	17
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib	17
Carcinoid Heart Disease: a Review	16
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?	16
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	16
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?	16
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts	16
Robotic Surgery for Head and Neck Tumors: What are the Current Applications?	16
New Insights on Tramadol and Immunomodulation	16

Treatment of Metastatic Melanoma in the Elderly	16
Management of Clinically Regional Node-Positive Urothelial Carcinoma of the Bladder	16
Brain Prehabilitation for Oncologic Surgery	16
Current Approaches to Philadelphia Chromosome–Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant	16
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?	16
The Microbiome’s Influence on Head and Neck Cancers	15
Oncolytic Viruses and Cancer Immunotherapy	15
Interventions to Reduce Sedentary Behavior in Cancer Patients and Survivors: a Systematic Review	15
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	15
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?	15
Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review	15
Bystander effect of antibody–drug conjugates: fact or fiction?	15
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy	15
How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?	15
Cardiotoxicity of Immune Checkpoint Inhibitors	14
Rare Breast Cancer Subtypes	14
Telehealth Utilization in Neuro-Oncology: Commentary on a Single Institution Experience After the COVID-19 Pandemic	14
Newly Diagnosed Glioblastoma in Elderly Patients	14
Tumor and Systemic Immunomodulatory Effects of MEK Inhibition	14
Correction to: New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology	14
Return to Intended Oncological Therapy: State of the Art and Perspectives	14
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review	14
Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan	14
The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic	14
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	14
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors	14
NRG1 Fusions: The New Kid on the Block	13
Molecular Profiling in Early ER + Breast Cancer to Aid Systemic Therapy Decisions	13
Richter Syndrome	13
Correction to: Current Status of Perioperative Therapy in Muscle‑Invasive Bladder Cancer and Future Directions	13
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?	13
Organizational Strategies for Providing Cancer Palliative Care to Many	13
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies	13
Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients	13
Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity	13
New Developments in VHL-Associated Neuroendocrine Neoplasms	13
Head and Neck Mucosal Melanoma: Where Are We Now?	13
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors	13
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	13
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	13
Integrative Approaches in the Treatment of Patients Affected by Lymphoma	12
DNA Repair Mechanisms and Therapeutic Targets in Glioma	12
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions	12
Cellular Therapy in NSCLC: Between Myth and Reality	12
Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia	12
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths	12
Emerging Role of Biomarkers in Testicular Germ Cell Tumors	12
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer	11
CDK4/6 inhibitors: The Devil is in the Detail	11
Radiation and Melanoma: Where Are We Now?	11
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	11
Management of In-Transit Metastases	11
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?	11
Is Myelodysplasia a Consequence of Normal Aging?	11
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	10
Neutropenia and Infection Prophylaxis in Childhood Cancer	10
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	10
Emerging Therapies for Transthyretin Amyloidosis	10
Prolymphocytic Leukaemia: an Update on Biology and Treatment	10
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?	10
Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022	10
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival	10
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment	10
Interventional Management of Portal Hypertension in Cancer Patients	10
Chronic Lymphocytic Leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease	10
Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors	10
Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base	10
Desmoid Fibromatosis: Management in an Era of Increasing Options	10
Correction to: The Changing Landscape of Lymphoma Associated with HIV Infection	10
Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future	10
A Systematic Review and Quality Assessment of Breast Cancer Clinical Practice Guidelines Providing Complementary and Alternative Medicine Recommendations	9
Geographical Disparities in Lung Cancer in Canada: A Review	9
Minimally Invasive Procedures in the Diagnosis and Treatment of Localized Prostate Cancer: an Interventional Radiologist’s Perspective	9
Update on Minimally Invasive Surgical Approaches for Rectal Cancer	9
Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data	9
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	9
Acupuncture for Cancer-Related Anorexia: a Review of the Current Evidence	9
Palliative Care in Pediatric Oncology and Hematopoietic Stem Cell Transplantation	9
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma	9
Perioperative Anticoagulation in Patients with Cancer	9

The Presence of Complementary and Alternative Medicine Recommendations in Head and Neck Cancer Guidelines: Systematic Review and Quality Assessment	9
Current Trends and Challenges of Microbiome Research in Prostate Cancer	9
Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum	9
Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma	9
Racial Disparities in Breast Cancer: from Detection to Treatment	8
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	8
Diagnosis and Management of Stroke in Adults with Primary Brain Tumor	8
Viral and Clinical Oncology of Head and Neck Cancers	8
Engineered T Cells: CAR T Cell Therapy and Beyond	8
Approaches to Non-Muscle-Invasive Bladder Cancer	8
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy	8
Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine Tumours	8
Interventional Strategies in Cancer-induced Cardiovascular Disease	8
The Role and Impact of Minimal Residual Disease in NSCLC	8
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?	8
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	8
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors	8
Anti-PD-1: When to Stop Treatment	8
Interventional Treatment Options for Post-mastectomy Pain	8
Correction to: Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions	8
New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors	8
Novel Clinical Trials and Approaches in the Management of Glioblastoma	8
Giant Cell Tumor of Bone: An Update	8
Art Therapy in Advanced Cancer. A Mapping Review of the Evidence	8
Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates	8
Melanoma in Pediatric and Young Adult Patients	8
Cardiac Effects of BRAF and MEK Inhibitors: Mechanisms and Clinical Management	8
An Overview of Angiogenesis in Bladder Cancer	7
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	7
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	7
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)	7
Telemedicine and Virtual Interventions in Cancer Rehabilitation: Practical Application, Complications and Future Potentials	7
Global Perceptions of Women on Breast Cancer and Barriers to Screening	7
Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer	7
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity	7
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas	7
Update on Management of Squamous Cell Esophageal Cancer	7
Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma	7
Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy	7
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer	7
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	7
Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being Undetectable	7
AXL Inhibitors: Status of Clinical Development	7
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients	7
The Microbiome in Advanced Melanoma: Where Are We Now?	7
Targeting the mu-Opioid Receptor for Cancer Treatment	7
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?	7
COVID and Lung Cancer	7
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?	6
ROS1 Targeted Therapies: Current Status	6
Disease Assessments in Patients with Glioblastoma	6
Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)	6
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?	6
Cardio-Oncology in Childhood: State of the Art	6
The Difficult Airway in Patients with Cancer	6
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients	6
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	6
Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies	6
Current Role of Functional Imaging in the Management of Lymphoma	6
Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy	6
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside	6
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?	6
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine	6
Developing a National Study That Integrates the Geriatric Assessment into the Care of Older Patients with Myeloid Malignancies	6
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)	6
Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches—Focus on EZH2-Targeted Drugs	6
Perioperative Neurocognitive Function in Glioma Surgery	6
Approach to Oligometastatic Cancer in the Elderly Patient	6
Correction: Newly Diagnosed Glioblastoma in Elderly Patients	6
Liver Cancer Etiology: Old Issues and New Perspectives	5
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review	5
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies	5
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?	5
Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer	5
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients	5
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	5
Current Clinical Trial Landscape of OX40 Agonists	5
Recent Progress in Mind–Body Therapies in Cancer Care	5
Palliative Rehabilitation in Patients with Cancer: Definitions, Structures, Processes and Outcomes	5
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?	5
Proton Therapy in The Treatment of Head And Neck Cancers- Review	5
3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?	5
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	5
Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors	5
Targeting the PI3K Pathway in Gynecologic Malignancies	5
Tele-neuro-oncology: Current Practices and Future Directions	5
CAR T-cell Therapy for Central Nervous System Lymphoma	5
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations	5
Integrative Approaches to Minimize Peri-operative Symptoms	5
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway	5
Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer	5
Exploring the Role of Target Expression in Treatment Efficacy of Antibody–Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review	5
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine	5
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature	5
Updates in Cardiac Amyloidosis Diagnosis and Treatment	5